内藤誠二 (Seiji Naito) - マイポータル - researchmap

基本情報

所属: 九州大学名誉教授

学位: 医学博士(九州大学)

J-GLOBAL ID: 200901091380175200
researchmap会員ID: 1000041587

研究キーワード

2

研究分野

1

ライフサイエンス / 泌尿器科学 /

MISC

145

Evaluation and management of prostate-specific antigen recurrence after radical prostatectomy for localized prostate cancer

S Naito

JAPANESE JOURNAL OF CLINICAL ONCOLOGY 35(7) 365-374 2005年7月
Inositol 1,4,5-trisphosphate (IP3) receptor type1 (IP(3)R1) modulates the acouisition of cisplatin resistance in bladder cancer cell lines

T Tsunoda, H Koga, A Yokomizo, K Tatsugami, M Eto, J Inokuchi, A Hirata, K Masuda, K Okumura, S Naito

ONCOGENE 24(8) 1396-1402 2005年2月
Anti-tumour activity of heat-shock protein 60-recognizing CD4(+) T cells against syngeneic murine renal cell carcinoma

M Eto, M Harada, K Tatsugami, M Harano, H Koga, G Matsuzaki, S Naito

BJU INTERNATIONAL 95(3) 420-423 2005年2月
Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats.（共著）

Br J Cancer 93 (6): 678-687 2005年
Curli fibers are required for development of biofilm architecture in escherichia coli K-12 and enhance bacterial adherence to human uroepithelial cells.（共著）

Microbiol Immunol 49 (9): 875-884 2005年
Functional role of PKC in contraction of cultured human prostatic stromal cells.（共著）

J Cell Biochem 96 (1): 65-78 2005年
Importance of urinary interleukin-18 in intravesical immunotherapy with bacillus calmette-guerin for superficial bladder tumors.（共著）

Urol Int 75 (2): 114-118 2005年
Overexpression of laminin-5 γ2 chain and its prognostic significance in urothelial carcinoma of urinary bladder: association with expression of cyclooxygenase 2, epidermal growth factor, and human epidermal growth factor 2.（共著）

Hum Pathol 36 (5): 522-530 2005年
Effectiveness of adjuvant intermittent endocrine therapy following neoadjuvant endocrine therapy and external beam radiation therapy in men with locally advanced prostate cancer.（共著）

Prostate 63 (1): 56-64 2005年
Adverse drug reactions of intravesical bacillus Calmette-Guerin instillation and risk factors of the development of adverse drug reactions in superficial cancer and carcinoma in situ of the bladder.（共著）

Int J Urol 12 (): 145-151 2005年
On the mechanism of cell lysis by deformation.（共著）

J Biomech 38 (1): 117-124 2005年
Association of HER-2 polymorphism with Japanese sporadic prostate cancer susceptibility

A Yokomizo, H Koga, N Kinukawa, T Tsukamoto, Y Hirao, H Akaza, M Mori, S Naito

PROSTATE 62(1) 49-53 2005年1月
HPC2/ELAC2 polymorphism associated with Japanese sporadic prostate cancer

A Yokomizo, H Koga, N Kinukawa, T Tsukamoto, Y Hirao, H Akaza, M Mori, S Naito

PROSTATE 61(3) 248-252 2004年11月
Characteristics of patients with prostate cancer who have initially been treated by hormone therapy in Japan: J-CaP surveillance.（共著）

Jpn J Clin Oncol 34 (6): 329-336 2004年
Risk factors for febrile urinary tract infection in children with myelodysplasia who were treated with clean intermittent catheterization.（共著）

Int J Urol 11: 973-977 2004年
Direct inhibition of EGF receptor activation in vascular endothelial cells by gefitinib ('lressa', ZD1839).（共著）

Cancer Sci 95 (7): 614-618 2004年
Detection of mycroplasma genitalium, mycroplasma hominis, ureaplasma parvum (biovar 1) and ureaplasma urealyticum (biovar 2) in patients with non-gonococcal urethritis using polymerase chain reaction-microtiter plate hybridization.（共著）

Int J Urol 11 (9): 750-754 2004年
Anatomical features of periprostatic tissue and its surroundings: a histological analysis of 79 radical retropubic prostatectomy specimens.（共著）

Jpn J Clin Oncol 34 (8): 463-468 2004年
Ca2＋ sensitization in contraction of human bladder smooth muscle.（共著）

J Urol 172 (2): 748-752 2004年
Superior anti-tumor efficacy of bicalutamide 80 mg in combination with a luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist monotherapy as first-line treatment for advanced prostate cancer: Interim results of a randomized study in・・・

Jpn J Clin Oncol 34 (1): 20-28 2004年

もっとみる

共同研究・競争的資金等の研究課題

6